• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

    44.91 -0.85 (-1.87%)
    Streaming Delayed Price Updated: 12:06 PM EDT, Oct 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Crinetics Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    11 Analysts Have This to Say About Crinetics Pharmaceuticals
     
    Via Benzinga
    Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Why Crinetics Pharmaceuticals Stock Soared This Week
    A positive late-stage trial readout fueled a major rally in the drugmaker's shares. 
    Via The Motley Fool
    Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX) Near the Top of Equities by Percentage Gain on 9/11
    Via Investor Brand Network
    10 Health Care Stocks Whale Activity In Today's Session
     
    Via Benzinga
    7 Speculative Stocks Set to Explode Higher
    On the search for high-risk, high-reward opportunities? Consider taking a look at these seven speculative stocks. 
    Via InvestorPlace
    Top 4 Health Care Stocks That Should Keep You Up At Night
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?
    Despite good results in phase 3 trials, there are barriers to its drug candidate's success. 
    Via The Motley Fool
    Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    What's Going On With Crinetics Pharmaceuticals Stock?
    Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) shares are trading higher Tuesday. 
    Via Benzinga
    Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Nasdaq Rises Over 1%; Hostess Brands Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P... 
    Via Benzinga
    Topics Stocks
    Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
     
    Via Benzinga
    Why Shares of Crinetics Pharmaceuticals Are Jumping Monday
    The biotech company reported positive phase 3 trial results. 
    Via The Motley Fool
    Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results
    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P... 
    Via Benzinga
    Topics Stocks
    Crinetics Pharma's Investigational Candidate Shows Promise In Rare Type Of Hormonal Disorder
    On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary  
    Via Benzinga
    Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 71%
    The company is working on a treatment for a growth hormone disorder. 
    Via Investor's Business Daily
    US Stocks Open Higher; Dow Jumps 150 Points
    U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 34,736.26 while the NASDAQ rose 0.94% to... 
    Via Benzinga
    Topics Stocks
    Why Is Nuwellis (NUWE) Stock Down Today?
    Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Why Is Tenon Medical (TNON) Stock Down 30% Today?
    Tenon Medical (TNON) stock is falling on Monday after the surgical implant company announced a proposed public offering for its shares. 
    Via InvestorPlace
    Why Is Versus Systems (VS) Stock Up 17% Today?
    Versus Systems (VS) stock is rising higher on Monday as the business software company's shares experience heavy trading this morning. 
    Via InvestorPlace
    Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Why Is Crinetics Pharmaceuticals (CRNX) Stock Up 64% Today?
    Crinetics Pharmaceuticals (CRNX) stock is on the rise Monday after the company announced positive clinical trial results. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
    Via InvestorPlace
    Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.